 Denis Bensard
Concepts (555)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Wounds, Nonpenetrating | 35 | 2022 | 312 | 7.240 |
Why?
| | Wounds and Injuries | 23 | 2025 | 941 | 4.390 |
Why?
| | Trauma Centers | 40 | 2023 | 469 | 4.200 |
Why?
| | Shock | 9 | 2025 | 105 | 3.740 |
Why?
| | Injury Severity Score | 45 | 2023 | 575 | 3.520 |
Why?
| | Abdominal Injuries | 13 | 2022 | 124 | 2.910 |
Why?
| | Blood Transfusion | 17 | 2022 | 401 | 2.650 |
Why?
| | Shock, Hemorrhagic | 6 | 2021 | 200 | 2.180 |
Why?
| | Glasgow Coma Scale | 8 | 2023 | 214 | 2.050 |
Why?
| | Wounds, Penetrating | 5 | 2023 | 74 | 1.830 |
Why?
| | Triage | 9 | 2025 | 252 | 1.690 |
Why?
| | Spleen | 7 | 2021 | 517 | 1.580 |
Why?
| | Craniocerebral Trauma | 6 | 2022 | 176 | 1.540 |
Why?
| | Child | 101 | 2025 | 22725 | 1.510 |
Why?
| | Brain Injuries | 9 | 2015 | 506 | 1.480 |
Why?
| | Blood Coagulation Disorders | 5 | 2022 | 191 | 1.420 |
Why?
| | Retrospective Studies | 73 | 2025 | 16741 | 1.410 |
Why?
| | Thoracic Injuries | 4 | 2018 | 70 | 1.370 |
Why?
| | Thoracotomy | 8 | 2020 | 82 | 1.350 |
Why?
| | Blood Component Transfusion | 3 | 2022 | 100 | 1.240 |
Why?
| | Child, Preschool | 62 | 2025 | 11737 | 1.150 |
Why?
| | Thrombelastography | 5 | 2022 | 175 | 1.110 |
Why?
| | Liver | 9 | 2021 | 1864 | 1.090 |
Why?
| | Tomography, X-Ray Computed | 15 | 2022 | 2779 | 1.060 |
Why?
| | Laparoscopy | 11 | 2015 | 474 | 1.060 |
Why?
| | Adolescent | 66 | 2025 | 22481 | 0.960 |
Why?
| | Appendicitis | 7 | 2021 | 146 | 0.960 |
Why?
| | Resuscitation | 5 | 2022 | 301 | 0.920 |
Why?
| | Appendectomy | 6 | 2021 | 89 | 0.920 |
Why?
| | Emergency Service, Hospital | 8 | 2023 | 2270 | 0.890 |
Why?
| | Hematocrit | 2 | 2015 | 104 | 0.870 |
Why?
| | Infant | 48 | 2025 | 9981 | 0.850 |
Why?
| | Erythrocyte Transfusion | 3 | 2022 | 211 | 0.780 |
Why?
| | Decision Support Techniques | 4 | 2022 | 438 | 0.780 |
Why?
| | Emergency Medical Services | 3 | 2023 | 685 | 0.760 |
Why?
| | Humans | 137 | 2025 | 143560 | 0.750 |
Why?
| | Severity of Illness Index | 4 | 2019 | 2936 | 0.750 |
Why?
| | Child Abuse | 6 | 2014 | 552 | 0.750 |
Why?
| | Heart Rate | 6 | 2023 | 844 | 0.750 |
Why?
| | Length of Stay | 13 | 2022 | 1279 | 0.730 |
Why?
| | Risk Adjustment | 1 | 2022 | 84 | 0.700 |
Why?
| | Early Medical Intervention | 1 | 2022 | 60 | 0.690 |
Why?
| | Blood Pressure | 7 | 2023 | 1755 | 0.680 |
Why?
| | Male | 100 | 2025 | 71500 | 0.670 |
Why?
| | Radiation Exposure | 1 | 2020 | 61 | 0.620 |
Why?
| | Intubation, Gastrointestinal | 3 | 2020 | 79 | 0.610 |
Why?
| | Hypotension | 3 | 2016 | 126 | 0.590 |
Why?
| | Patient Selection | 2 | 2022 | 691 | 0.580 |
Why?
| | Female | 78 | 2025 | 77251 | 0.570 |
Why?
| | Pylorus | 2 | 2010 | 18 | 0.570 |
Why?
| | Pyloric Stenosis, Hypertrophic | 2 | 2010 | 10 | 0.570 |
Why?
| | Enteral Nutrition | 2 | 2020 | 220 | 0.560 |
Why?
| | Catheterization, Central Venous | 2 | 2018 | 117 | 0.560 |
Why?
| | Hospitals, Pediatric | 4 | 2018 | 557 | 0.540 |
Why?
| | Lung Diseases | 7 | 2022 | 787 | 0.540 |
Why?
| | Colorado | 26 | 2022 | 4658 | 0.530 |
Why?
| | Head Injuries, Closed | 3 | 2012 | 49 | 0.490 |
Why?
| | Bacteremia | 1 | 2018 | 219 | 0.490 |
Why?
| | Bicycling | 1 | 2017 | 122 | 0.480 |
Why?
| | Hemoglobins | 3 | 2022 | 365 | 0.480 |
Why?
| | Upper Gastrointestinal Tract | 1 | 2015 | 12 | 0.470 |
Why?
| | Brain Injuries, Traumatic | 1 | 2021 | 432 | 0.460 |
Why?
| | Gastrostomy | 2 | 2015 | 133 | 0.460 |
Why?
| | Intestinal Volvulus | 1 | 2015 | 23 | 0.460 |
Why?
| | Rehydration Solutions | 1 | 2014 | 8 | 0.440 |
Why?
| | Isotonic Solutions | 1 | 2014 | 39 | 0.440 |
Why?
| | Lung | 14 | 2022 | 4101 | 0.440 |
Why?
| | Shock, Traumatic | 1 | 2014 | 15 | 0.440 |
Why?
| | Thrombosis | 1 | 2018 | 401 | 0.440 |
Why?
| | Age Factors | 10 | 2025 | 3328 | 0.420 |
Why?
| | Infant, Newborn | 17 | 2020 | 6366 | 0.410 |
Why?
| | Multiple Trauma | 7 | 2014 | 118 | 0.410 |
Why?
| | Preoperative Care | 2 | 2015 | 380 | 0.410 |
Why?
| | Vascular System Injuries | 3 | 2021 | 77 | 0.400 |
Why?
| | Gastroesophageal Reflux | 1 | 2015 | 244 | 0.380 |
Why?
| | Neoplasms, Radiation-Induced | 1 | 2013 | 98 | 0.380 |
Why?
| | Acidosis | 1 | 2013 | 105 | 0.380 |
Why?
| | Critical Illness | 2 | 2018 | 869 | 0.370 |
Why?
| | Laparotomy | 7 | 2023 | 116 | 0.370 |
Why?
| | Tracheostomy | 1 | 2014 | 145 | 0.370 |
Why?
| | Registries | 12 | 2025 | 2238 | 0.370 |
Why?
| | Risk Assessment | 4 | 2021 | 3577 | 0.370 |
Why?
| | Sensitivity and Specificity | 6 | 2022 | 1984 | 0.360 |
Why?
| | Referral and Consultation | 1 | 2018 | 828 | 0.360 |
Why?
| | Risk Factors | 15 | 2022 | 10644 | 0.360 |
Why?
| | Prognosis | 10 | 2023 | 4152 | 0.350 |
Why?
| | Spinal Cord Injuries | 2 | 2014 | 238 | 0.330 |
Why?
| | Treatment Outcome | 18 | 2020 | 11365 | 0.310 |
Why?
| | Mass Screening | 2 | 2019 | 1334 | 0.280 |
Why?
| | Viscera | 2 | 2005 | 17 | 0.270 |
Why?
| | Survival Rate | 9 | 2025 | 2003 | 0.270 |
Why?
| | Critical Pathways | 1 | 2009 | 108 | 0.270 |
Why?
| | Wounds, Gunshot | 2 | 2022 | 251 | 0.270 |
Why?
| | Lipopolysaccharides | 10 | 2004 | 861 | 0.260 |
Why?
| | Thoracoscopy | 4 | 2006 | 62 | 0.260 |
Why?
| | Adult | 31 | 2025 | 40013 | 0.250 |
Why?
| | Accidents, Home | 2 | 2004 | 33 | 0.250 |
Why?
| | Endotoxins | 7 | 1999 | 213 | 0.250 |
Why?
| | Pyelonephritis, Xanthogranulomatous | 1 | 2006 | 3 | 0.240 |
Why?
| | Radiation Dosage | 2 | 2020 | 195 | 0.230 |
Why?
| | Heart Arrest | 3 | 2018 | 399 | 0.230 |
Why?
| | Carcinoma, Papillary | 1 | 2025 | 80 | 0.220 |
Why?
| | Receptors, Adrenergic, beta | 3 | 1994 | 66 | 0.220 |
Why?
| | Digestive System Surgical Procedures | 1 | 2005 | 109 | 0.220 |
Why?
| | Follow-Up Studies | 9 | 2022 | 5308 | 0.210 |
Why?
| | Surgeons | 2 | 2021 | 336 | 0.210 |
Why?
| | Leg Injuries | 1 | 2004 | 25 | 0.210 |
Why?
| | Incidence | 12 | 2020 | 2844 | 0.210 |
Why?
| | Neutrophils | 13 | 2002 | 1134 | 0.210 |
Why?
| | Surgical Wound | 1 | 2023 | 27 | 0.190 |
Why?
| | Intestines | 2 | 2004 | 356 | 0.190 |
Why?
| | Precipitating Factors | 1 | 2022 | 6 | 0.180 |
Why?
| | Anticoagulants | 3 | 2019 | 728 | 0.180 |
Why?
| | Pediatric Emergency Medicine | 1 | 2022 | 24 | 0.180 |
Why?
| | Enterocolitis, Neutropenic | 1 | 2021 | 5 | 0.180 |
Why?
| | False Positive Reactions | 1 | 2022 | 122 | 0.180 |
Why?
| | Heart Injuries | 1 | 2021 | 41 | 0.170 |
Why?
| | Intracranial Pressure | 1 | 2022 | 61 | 0.170 |
Why?
| | Fundoplication | 2 | 2015 | 56 | 0.170 |
Why?
| | Hypovolemia | 1 | 2021 | 12 | 0.170 |
Why?
| | Logistic Models | 3 | 2016 | 2107 | 0.170 |
Why?
| | Jejunostomy | 1 | 2020 | 12 | 0.170 |
Why?
| | Early Diagnosis | 1 | 2022 | 247 | 0.160 |
Why?
| | Intraoperative Complications | 1 | 2022 | 155 | 0.160 |
Why?
| | Time Factors | 10 | 2014 | 7031 | 0.160 |
Why?
| | Frailty | 1 | 2023 | 180 | 0.160 |
Why?
| | Stomach | 1 | 2020 | 117 | 0.160 |
Why?
| | Plasma | 1 | 2022 | 222 | 0.160 |
Why?
| | Postoperative Care | 3 | 2019 | 281 | 0.160 |
Why?
| | Prospective Studies | 7 | 2022 | 7899 | 0.160 |
Why?
| | Hospital Mortality | 2 | 2014 | 962 | 0.150 |
Why?
| | Cerebrovascular Trauma | 1 | 2019 | 22 | 0.150 |
Why?
| | Salmonella typhimurium | 6 | 2002 | 190 | 0.150 |
Why?
| | Phlebotomy | 1 | 2019 | 20 | 0.150 |
Why?
| | Heart | 2 | 1994 | 632 | 0.150 |
Why?
| | Mortality | 1 | 2022 | 364 | 0.150 |
Why?
| | Respiration, Artificial | 3 | 2014 | 705 | 0.150 |
Why?
| | Monitoring, Physiologic | 1 | 2021 | 289 | 0.150 |
Why?
| | Diagnosis, Differential | 5 | 2014 | 1504 | 0.140 |
Why?
| | Firearms | 2 | 2022 | 402 | 0.140 |
Why?
| | Central Venous Catheters | 1 | 2018 | 50 | 0.140 |
Why?
| | Isoproterenol | 4 | 1998 | 101 | 0.140 |
Why?
| | United States | 8 | 2025 | 15553 | 0.140 |
Why?
| | Platelet Activating Factor | 3 | 1992 | 48 | 0.140 |
Why?
| | Trauma Severity Indices | 4 | 2013 | 111 | 0.140 |
Why?
| | Cholestasis | 1 | 2000 | 217 | 0.140 |
Why?
| | Colforsin | 4 | 2001 | 48 | 0.130 |
Why?
| | Feasibility Studies | 1 | 2022 | 1051 | 0.130 |
Why?
| | Abdomen, Acute | 1 | 1997 | 22 | 0.130 |
Why?
| | Patient Readmission | 2 | 2020 | 706 | 0.130 |
Why?
| | Stroke | 2 | 2019 | 1213 | 0.130 |
Why?
| | Pancreatic Neoplasms | 1 | 2025 | 924 | 0.130 |
Why?
| | Hospitalization | 4 | 2016 | 2313 | 0.130 |
Why?
| | Neoplasm Recurrence, Local | 2 | 2022 | 1095 | 0.130 |
Why?
| | Immune System Diseases | 1 | 1997 | 40 | 0.130 |
Why?
| | Algorithms | 2 | 2021 | 1813 | 0.130 |
Why?
| | Hospital Charges | 1 | 2016 | 44 | 0.130 |
Why?
| | Health Care Costs | 1 | 2020 | 423 | 0.130 |
Why?
| | Surgery Department, Hospital | 1 | 2016 | 23 | 0.130 |
Why?
| | Cardiopulmonary Resuscitation | 2 | 2015 | 334 | 0.120 |
Why?
| | Hospital Rapid Response Team | 1 | 2016 | 21 | 0.120 |
Why?
| | Reproducibility of Results | 2 | 2015 | 3380 | 0.120 |
Why?
| | Myocardial Reperfusion Injury | 4 | 1992 | 140 | 0.120 |
Why?
| | Cause of Death | 2 | 2014 | 459 | 0.120 |
Why?
| | Chemokines | 3 | 2001 | 223 | 0.120 |
Why?
| | Multiple Organ Failure | 4 | 2003 | 127 | 0.120 |
Why?
| | Exsanguination | 2 | 2012 | 20 | 0.120 |
Why?
| | Hemostatic Techniques | 1 | 2016 | 52 | 0.120 |
Why?
| | Splenectomy | 1 | 2015 | 61 | 0.120 |
Why?
| | Medical Futility | 1 | 2015 | 31 | 0.120 |
Why?
| | Intensive Care Units | 1 | 2022 | 886 | 0.120 |
Why?
| | Funnel Chest | 2 | 2005 | 29 | 0.120 |
Why?
| | Research Design | 1 | 2022 | 1123 | 0.110 |
Why?
| | Intestine, Small | 1 | 1996 | 159 | 0.110 |
Why?
| | Specialization | 1 | 2016 | 135 | 0.110 |
Why?
| | Arterial Occlusive Diseases | 1 | 1995 | 89 | 0.110 |
Why?
| | Benchmarking | 1 | 2016 | 183 | 0.110 |
Why?
| | Ultrasonography | 4 | 2010 | 769 | 0.110 |
Why?
| | Accidents | 1 | 2014 | 45 | 0.110 |
Why?
| | Child Advocacy | 1 | 2014 | 32 | 0.110 |
Why?
| | Nervous System Diseases | 1 | 1997 | 280 | 0.100 |
Why?
| | Critical Care | 3 | 2013 | 684 | 0.100 |
Why?
| | Craniotomy | 1 | 2014 | 82 | 0.100 |
Why?
| | Macrophages, Peritoneal | 2 | 2004 | 89 | 0.100 |
Why?
| | Rats | 19 | 2002 | 5610 | 0.100 |
Why?
| | Needs Assessment | 1 | 2016 | 392 | 0.100 |
Why?
| | Radiography, Thoracic | 2 | 2013 | 180 | 0.100 |
Why?
| | Intubation, Intratracheal | 1 | 2016 | 313 | 0.100 |
Why?
| | Fluid Therapy | 1 | 2014 | 143 | 0.100 |
Why?
| | Hemorrhage | 2 | 2016 | 804 | 0.100 |
Why?
| | Predictive Value of Tests | 4 | 2013 | 2086 | 0.100 |
Why?
| | Motor Skills | 1 | 2014 | 105 | 0.100 |
Why?
| | Contrast Media | 2 | 2015 | 479 | 0.100 |
Why?
| | Patient Outcome Assessment | 1 | 2014 | 132 | 0.100 |
Why?
| | Tracheotomy | 1 | 2013 | 25 | 0.100 |
Why?
| | Embolization, Therapeutic | 1 | 2015 | 245 | 0.100 |
Why?
| | Pandemics | 1 | 2022 | 1668 | 0.100 |
Why?
| | Young Adult | 7 | 2025 | 13972 | 0.100 |
Why?
| | Thrombophilia | 1 | 2013 | 90 | 0.100 |
Why?
| | Urinalysis | 1 | 2013 | 80 | 0.100 |
Why?
| | Coronary Disease | 1 | 1995 | 373 | 0.100 |
Why?
| | Unnecessary Procedures | 1 | 2013 | 54 | 0.100 |
Why?
| | Interleukin-10 | 3 | 2004 | 311 | 0.100 |
Why?
| | Vascular Surgical Procedures | 2 | 2012 | 341 | 0.090 |
Why?
| | Blood Group Incompatibility | 1 | 2012 | 17 | 0.090 |
Why?
| | Forecasting | 1 | 2014 | 384 | 0.090 |
Why?
| | Television | 1 | 1993 | 72 | 0.090 |
Why?
| | Postoperative Complications | 6 | 2022 | 2887 | 0.090 |
Why?
| | Abdominal Wound Closure Techniques | 1 | 2012 | 6 | 0.090 |
Why?
| | Phenytoin | 1 | 2012 | 21 | 0.090 |
Why?
| | Catheter-Related Infections | 1 | 2013 | 94 | 0.090 |
Why?
| | Piracetam | 1 | 2012 | 13 | 0.090 |
Why?
| | Angiography, Digital Subtraction | 1 | 2012 | 46 | 0.090 |
Why?
| | Electroencephalography | 1 | 2015 | 531 | 0.090 |
Why?
| | Orthopedic Procedures | 1 | 2014 | 233 | 0.090 |
Why?
| | Patient Education as Topic | 1 | 2016 | 783 | 0.090 |
Why?
| | Vasodilation | 4 | 1999 | 515 | 0.090 |
Why?
| | Chemokines, CXC | 2 | 2002 | 70 | 0.090 |
Why?
| | Aged | 8 | 2025 | 25322 | 0.090 |
Why?
| | Surgical Procedures, Operative | 1 | 2014 | 274 | 0.080 |
Why?
| | Neutrophil Infiltration | 2 | 2002 | 105 | 0.080 |
Why?
| | Urinary Tract Infections | 1 | 2013 | 200 | 0.080 |
Why?
| | Thyroidectomy | 1 | 2011 | 98 | 0.080 |
Why?
| | Rats, Sprague-Dawley | 10 | 2002 | 2531 | 0.080 |
Why?
| | Acute Disease | 6 | 2021 | 1015 | 0.080 |
Why?
| | Fat Necrosis | 1 | 1990 | 12 | 0.080 |
Why?
| | Myocardium | 4 | 1993 | 928 | 0.080 |
Why?
| | Cardiovascular Agents | 1 | 2011 | 158 | 0.080 |
Why?
| | Specialties, Surgical | 1 | 2011 | 80 | 0.080 |
Why?
| | Endocrinology | 1 | 2011 | 77 | 0.080 |
Why?
| | Triamcinolone | 1 | 1989 | 13 | 0.080 |
Why?
| | Pericardium | 1 | 1990 | 61 | 0.080 |
Why?
| | Practice Guidelines as Topic | 2 | 2019 | 1557 | 0.080 |
Why?
| | Multivariate Analysis | 1 | 2013 | 1510 | 0.080 |
Why?
| | Diaphragm | 2 | 2004 | 46 | 0.080 |
Why?
| | Chest Pain | 1 | 1990 | 96 | 0.080 |
Why?
| | Intercellular Signaling Peptides and Proteins | 2 | 2002 | 389 | 0.080 |
Why?
| | Anticonvulsants | 1 | 2012 | 229 | 0.080 |
Why?
| | Suppuration | 1 | 2009 | 9 | 0.080 |
Why?
| | Biopsy | 1 | 1993 | 1083 | 0.080 |
Why?
| | Cerebrovascular Circulation | 1 | 2011 | 272 | 0.080 |
Why?
| | Esophageal Stenosis | 1 | 1989 | 57 | 0.080 |
Why?
| | Necrosis | 1 | 1990 | 247 | 0.070 |
Why?
| | Oxygen | 2 | 1994 | 998 | 0.070 |
Why?
| | Pulmonary Fibrosis | 1 | 1993 | 392 | 0.070 |
Why?
| | Tumor Necrosis Factor-alpha | 5 | 2004 | 1226 | 0.070 |
Why?
| | Middle Aged | 10 | 2025 | 35342 | 0.070 |
Why?
| | Pediatrics | 2 | 2011 | 1124 | 0.070 |
Why?
| | Perioperative Care | 1 | 2011 | 234 | 0.070 |
Why?
| | General Surgery | 1 | 2011 | 205 | 0.070 |
Why?
| | Asparaginase | 2 | 1998 | 30 | 0.070 |
Why?
| | Seizures | 1 | 2012 | 454 | 0.070 |
Why?
| | Accidents, Traffic | 4 | 2011 | 192 | 0.070 |
Why?
| | Pulmonary Artery | 3 | 2000 | 1123 | 0.070 |
Why?
| | Aorta, Thoracic | 2 | 2021 | 285 | 0.070 |
Why?
| | Patient Discharge | 2 | 2016 | 923 | 0.070 |
Why?
| | Cyclic AMP | 2 | 2001 | 215 | 0.070 |
Why?
| | Minimally Invasive Surgical Procedures | 2 | 2005 | 184 | 0.070 |
Why?
| | Hernia, Inguinal | 2 | 1998 | 42 | 0.060 |
Why?
| | Pancreatitis | 2 | 1998 | 136 | 0.060 |
Why?
| | Biliary Atresia | 2 | 2000 | 154 | 0.060 |
Why?
| | Pilot Projects | 1 | 2012 | 1838 | 0.060 |
Why?
| | Endotoxemia | 3 | 2002 | 87 | 0.060 |
Why?
| | Mediastinal Neoplasms | 1 | 2006 | 51 | 0.060 |
Why?
| | Hepatic Artery | 1 | 2006 | 52 | 0.060 |
Why?
| | Ventriculoperitoneal Shunt | 1 | 2006 | 41 | 0.060 |
Why?
| | Mediastinum | 1 | 2005 | 22 | 0.060 |
Why?
| | Brachial Plexus | 1 | 2005 | 34 | 0.060 |
Why?
| | Rats, Inbred Strains | 8 | 1992 | 332 | 0.060 |
Why?
| | Signal Transduction | 2 | 2002 | 5214 | 0.060 |
Why?
| | Patient Care Team | 1 | 2011 | 690 | 0.060 |
Why?
| | Nevus, Epithelioid and Spindle Cell | 1 | 2005 | 14 | 0.060 |
Why?
| | Neuroblastoma | 1 | 2006 | 165 | 0.060 |
Why?
| | Hospitals, Teaching | 1 | 2005 | 115 | 0.060 |
Why?
| | Anti-Bacterial Agents | 1 | 2016 | 1906 | 0.060 |
Why?
| | Chemotactic Factors | 2 | 2002 | 43 | 0.060 |
Why?
| | Evidence-Based Medicine | 1 | 2009 | 724 | 0.060 |
Why?
| | Kidney | 3 | 2004 | 1507 | 0.060 |
Why?
| | Neoplasm Staging | 2 | 2025 | 1416 | 0.060 |
Why?
| | Growth Substances | 2 | 2002 | 140 | 0.060 |
Why?
| | Pulmonary Edema | 2 | 2002 | 110 | 0.050 |
Why?
| | Cohort Studies | 1 | 2015 | 5891 | 0.050 |
Why?
| | Heparin | 2 | 2019 | 254 | 0.050 |
Why?
| | Sentinel Lymph Node Biopsy | 1 | 2005 | 115 | 0.050 |
Why?
| | Renal Veins | 1 | 2004 | 18 | 0.050 |
Why?
| | Leisure Activities | 1 | 2004 | 30 | 0.050 |
Why?
| | Renal Artery | 1 | 2004 | 43 | 0.050 |
Why?
| | Physical Examination | 2 | 2014 | 245 | 0.050 |
Why?
| | Thoracic Surgical Procedures | 1 | 2005 | 94 | 0.050 |
Why?
| | Intestinal Perforation | 1 | 2004 | 46 | 0.050 |
Why?
| | Peroxidase | 7 | 2002 | 174 | 0.050 |
Why?
| | Granuloma, Plasma Cell | 1 | 2003 | 12 | 0.050 |
Why?
| | Comorbidity | 3 | 2023 | 1678 | 0.050 |
Why?
| | Hernia, Diaphragmatic | 1 | 2003 | 66 | 0.050 |
Why?
| | Age Distribution | 5 | 2003 | 398 | 0.050 |
Why?
| | Animals | 24 | 2002 | 38010 | 0.050 |
Why?
| | Twins, Conjoined | 1 | 2003 | 6 | 0.050 |
Why?
| | Nephrectomy | 1 | 2004 | 159 | 0.050 |
Why?
| | Pleural Effusion | 1 | 2003 | 60 | 0.050 |
Why?
| | Rib Fractures | 1 | 2003 | 33 | 0.050 |
Why?
| | Vital Signs | 1 | 2023 | 49 | 0.050 |
Why?
| | Pancreatectomy | 1 | 2025 | 267 | 0.050 |
Why?
| | Fluoroscopy | 1 | 2003 | 171 | 0.050 |
Why?
| | Heparin, Low-Molecular-Weight | 1 | 2022 | 38 | 0.050 |
Why?
| | Anal Canal | 1 | 2003 | 101 | 0.050 |
Why?
| | Solitary Pulmonary Nodule | 1 | 2002 | 21 | 0.050 |
Why?
| | Frail Elderly | 1 | 2023 | 132 | 0.050 |
Why?
| | Diseases in Twins | 1 | 2003 | 159 | 0.050 |
Why?
| | Chemokine CXCL2 | 4 | 2002 | 42 | 0.050 |
Why?
| | Peritonitis | 1 | 2002 | 83 | 0.040 |
Why?
| | Rectum | 1 | 2003 | 187 | 0.040 |
Why?
| | Receptors, Cell Surface | 2 | 2002 | 379 | 0.040 |
Why?
| | Bites and Stings | 1 | 2001 | 29 | 0.040 |
Why?
| | Patients | 1 | 2023 | 180 | 0.040 |
Why?
| | Abnormalities, Multiple | 1 | 2003 | 197 | 0.040 |
Why?
| | Receptors, Tumor Necrosis Factor | 1 | 2001 | 166 | 0.040 |
Why?
| | Inflammation Mediators | 1 | 2004 | 510 | 0.040 |
Why?
| | Receptors, Interleukin-1 | 1 | 2002 | 215 | 0.040 |
Why?
| | Consensus | 1 | 2023 | 550 | 0.040 |
Why?
| | Pulmonary Circulation | 2 | 1999 | 425 | 0.040 |
Why?
| | Receptors, Chemokine | 1 | 2000 | 48 | 0.040 |
Why?
| | Drosophila Proteins | 1 | 2002 | 208 | 0.040 |
Why?
| | Joint Dislocations | 1 | 2000 | 56 | 0.040 |
Why?
| | Interleukin-1 | 1 | 2004 | 970 | 0.040 |
Why?
| | Abbreviated Injury Scale | 1 | 2019 | 24 | 0.040 |
Why?
| | Administrative Claims, Healthcare | 1 | 2019 | 26 | 0.040 |
Why?
| | Sex Distribution | 4 | 2002 | 383 | 0.040 |
Why?
| | Hydrogen Peroxide | 2 | 1992 | 339 | 0.040 |
Why?
| | Arginine | 1 | 2001 | 261 | 0.040 |
Why?
| | Surgical Wound Infection | 1 | 2023 | 328 | 0.040 |
Why?
| | Membrane Glycoproteins | 1 | 2002 | 498 | 0.040 |
Why?
| | Nitric Oxide Synthase | 1 | 2000 | 241 | 0.040 |
Why?
| | Cervical Vertebrae | 1 | 2000 | 150 | 0.040 |
Why?
| | Datasets as Topic | 1 | 2019 | 127 | 0.040 |
Why?
| | Odds Ratio | 1 | 2022 | 1060 | 0.040 |
Why?
| | Morbidity | 2 | 2014 | 321 | 0.040 |
Why?
| | Salmonella typhi | 1 | 1998 | 13 | 0.040 |
Why?
| | Aged, 80 and over | 3 | 2023 | 8072 | 0.040 |
Why?
| | Receptors, Adrenergic, alpha | 2 | 2000 | 20 | 0.040 |
Why?
| | Hernia, Femoral | 1 | 1998 | 4 | 0.040 |
Why?
| | Antigens, CD | 1 | 2001 | 549 | 0.040 |
Why?
| | Edema | 1 | 1999 | 127 | 0.040 |
Why?
| | Monocytes | 1 | 2001 | 545 | 0.040 |
Why?
| | Monokines | 3 | 2002 | 22 | 0.040 |
Why?
| | Melanoma | 1 | 2005 | 807 | 0.030 |
Why?
| | Octreotide | 1 | 1998 | 26 | 0.030 |
Why?
| | Poly(ADP-ribose) Polymerase Inhibitors | 1 | 1999 | 134 | 0.030 |
Why?
| | Skin Neoplasms | 1 | 2005 | 869 | 0.030 |
Why?
| | Cecal Diseases | 1 | 1997 | 3 | 0.030 |
Why?
| | Pneumonia | 1 | 2003 | 647 | 0.030 |
Why?
| | Analysis of Variance | 4 | 2004 | 1314 | 0.030 |
Why?
| | Aorta | 1 | 2000 | 433 | 0.030 |
Why?
| | Platelet Aggregation Inhibitors | 2 | 2011 | 485 | 0.030 |
Why?
| | Survivors | 1 | 2020 | 502 | 0.030 |
Why?
| | Hospitals | 1 | 2021 | 691 | 0.030 |
Why?
| | Perfusion | 3 | 1992 | 242 | 0.030 |
Why?
| | Leukocyte Count | 2 | 2002 | 317 | 0.030 |
Why?
| | Abdominal Pain | 1 | 1997 | 144 | 0.030 |
Why?
| | In Vitro Techniques | 3 | 1992 | 1064 | 0.030 |
Why?
| | Portoenterostomy, Hepatic | 1 | 1996 | 43 | 0.030 |
Why?
| | Aspirin | 1 | 2019 | 398 | 0.030 |
Why?
| | Cystic Duct | 1 | 1996 | 3 | 0.030 |
Why?
| | Hepatic Duct, Common | 1 | 1996 | 5 | 0.030 |
Why?
| | Reoperation | 2 | 2012 | 605 | 0.030 |
Why?
| | Sepsis | 1 | 2002 | 638 | 0.030 |
Why?
| | Injections, Intravenous | 1 | 2016 | 203 | 0.030 |
Why?
| | Cholecystectomy, Laparoscopic | 1 | 1996 | 52 | 0.030 |
Why?
| | Ketone Bodies | 2 | 1992 | 14 | 0.030 |
Why?
| | Recovery of Function | 2 | 2015 | 702 | 0.030 |
Why?
| | Receptors, Purinergic P1 | 1 | 1994 | 30 | 0.030 |
Why?
| | Stomach Volvulus | 1 | 1994 | 2 | 0.030 |
Why?
| | Radiography | 3 | 2003 | 846 | 0.030 |
Why?
| | Disease-Free Survival | 2 | 2006 | 720 | 0.030 |
Why?
| | Pneumothorax | 2 | 2005 | 51 | 0.030 |
Why?
| | Ventricular Pressure | 1 | 1994 | 49 | 0.030 |
Why?
| | Tetralones | 1 | 1993 | 1 | 0.030 |
Why?
| | Adenylyl Cyclases | 1 | 1994 | 62 | 0.030 |
Why?
| | Myocardial Reperfusion | 1 | 1993 | 53 | 0.030 |
Why?
| | Cardiac Output | 1 | 1994 | 179 | 0.030 |
Why?
| | Thoracoscopes | 1 | 1993 | 2 | 0.020 |
Why?
| | Administration, Oral | 1 | 2016 | 842 | 0.020 |
Why?
| | Conversion to Open Surgery | 1 | 2013 | 18 | 0.020 |
Why?
| | Evaluation Studies as Topic | 1 | 1993 | 172 | 0.020 |
Why?
| | Combined Modality Therapy | 1 | 2016 | 1252 | 0.020 |
Why?
| | NF-kappa B | 3 | 2001 | 685 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 2 | 1998 | 2056 | 0.020 |
Why?
| | Myocardial Contraction | 1 | 1994 | 300 | 0.020 |
Why?
| | Oligopeptides | 2 | 1991 | 266 | 0.020 |
Why?
| | Acetoacetates | 1 | 1992 | 2 | 0.020 |
Why?
| | Surgical Sponges | 1 | 2012 | 5 | 0.020 |
Why?
| | Hydroxybutyrates | 1 | 1992 | 16 | 0.020 |
Why?
| | Cost Control | 1 | 2012 | 37 | 0.020 |
Why?
| | Vertebral Artery | 1 | 2011 | 27 | 0.020 |
Why?
| | Decision Trees | 1 | 2012 | 81 | 0.020 |
Why?
| | Negative-Pressure Wound Therapy | 1 | 2012 | 30 | 0.020 |
Why?
| | Carotid Artery Injuries | 1 | 2011 | 40 | 0.020 |
Why?
| | Myocardial Ischemia | 1 | 1993 | 279 | 0.020 |
Why?
| | Blood Coagulation | 1 | 2013 | 271 | 0.020 |
Why?
| | Fever | 1 | 2013 | 310 | 0.020 |
Why?
| | Chemokine CXCL1 | 2 | 2002 | 77 | 0.020 |
Why?
| | Monte Carlo Method | 1 | 2012 | 154 | 0.020 |
Why?
| | Lipid A | 1 | 1991 | 27 | 0.020 |
Why?
| | Platelet Membrane Glycoproteins | 1 | 1991 | 35 | 0.020 |
Why?
| | Pelvic Bones | 1 | 1993 | 132 | 0.020 |
Why?
| | Endovascular Procedures | 1 | 2016 | 375 | 0.020 |
Why?
| | Cytokines | 1 | 1999 | 2097 | 0.020 |
Why?
| | Angiography | 1 | 2011 | 207 | 0.020 |
Why?
| | Thyroid Diseases | 1 | 2011 | 45 | 0.020 |
Why?
| | Neoplastic Syndromes, Hereditary | 1 | 2011 | 43 | 0.020 |
Why?
| | Hospitals, University | 1 | 2011 | 176 | 0.020 |
Why?
| | Pancreatic Elastase | 1 | 1990 | 56 | 0.020 |
Why?
| | Enzyme Induction | 1 | 1990 | 89 | 0.020 |
Why?
| | Drug Costs | 1 | 2012 | 115 | 0.020 |
Why?
| | Thyroid Nodule | 1 | 2011 | 56 | 0.020 |
Why?
| | Clinical Protocols | 1 | 2012 | 279 | 0.020 |
Why?
| | Antioxidants | 2 | 1991 | 594 | 0.020 |
Why?
| | Interdisciplinary Communication | 1 | 2011 | 198 | 0.020 |
Why?
| | Survival Analysis | 2 | 2003 | 1332 | 0.020 |
Why?
| | Cyclic GMP | 2 | 1999 | 91 | 0.020 |
Why?
| | Growth Disorders | 1 | 1989 | 87 | 0.020 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 1991 | 219 | 0.020 |
Why?
| | Reperfusion Injury | 1 | 1992 | 292 | 0.020 |
Why?
| | RNA, Messenger | 3 | 2002 | 2852 | 0.020 |
Why?
| | Fibrinolytic Agents | 1 | 2011 | 287 | 0.020 |
Why?
| | Lung Neoplasms | 1 | 2002 | 2580 | 0.020 |
Why?
| | Shock, Septic | 1 | 1991 | 219 | 0.020 |
Why?
| | Cost-Benefit Analysis | 1 | 2012 | 621 | 0.020 |
Why?
| | Liver Diseases | 1 | 1992 | 304 | 0.020 |
Why?
| | Radiology | 1 | 2011 | 172 | 0.020 |
Why?
| | Glutathione | 1 | 1990 | 373 | 0.020 |
Why?
| | Fractures, Bone | 1 | 1993 | 413 | 0.020 |
Why?
| | Medical Oncology | 1 | 2011 | 328 | 0.020 |
Why?
| | Cooperative Behavior | 1 | 2011 | 458 | 0.020 |
Why?
| | Thyroid Neoplasms | 1 | 2011 | 337 | 0.020 |
Why?
| | Antineoplastic Agents | 1 | 1998 | 2195 | 0.020 |
Why?
| | Oxidation-Reduction | 1 | 1990 | 1091 | 0.020 |
Why?
| | Serum Albumin | 3 | 1992 | 150 | 0.020 |
Why?
| | Enzyme Inhibitors | 2 | 2000 | 839 | 0.020 |
Why?
| | Intestinal Mucosa | 1 | 1992 | 664 | 0.010 |
Why?
| | Tissue Adhesions | 1 | 2006 | 33 | 0.010 |
Why?
| | Equipment Failure | 1 | 2006 | 112 | 0.010 |
Why?
| | Arm | 1 | 2005 | 109 | 0.010 |
Why?
| | Hydrocephalus | 1 | 2006 | 110 | 0.010 |
Why?
| | Hypertension, Renovascular | 1 | 2004 | 15 | 0.010 |
Why?
| | Posture | 1 | 2005 | 197 | 0.010 |
Why?
| | Lymphatic Metastasis | 1 | 2005 | 328 | 0.010 |
Why?
| | Rupture | 1 | 2004 | 88 | 0.010 |
Why?
| | Subclavian Vein | 1 | 2003 | 15 | 0.010 |
Why?
| | Hemothorax | 1 | 2003 | 13 | 0.010 |
Why?
| | Abdominal Abscess | 1 | 2003 | 25 | 0.010 |
Why?
| | Jugular Veins | 1 | 2003 | 42 | 0.010 |
Why?
| | Rectovaginal Fistula | 1 | 2003 | 11 | 0.010 |
Why?
| | Appendix | 1 | 2003 | 31 | 0.010 |
Why?
| | Fetal Death | 1 | 2003 | 59 | 0.010 |
Why?
| | Gene Expression Regulation | 2 | 2004 | 2621 | 0.010 |
Why?
| | Zymosan | 1 | 2002 | 40 | 0.010 |
Why?
| | Creatinine | 1 | 2004 | 494 | 0.010 |
Why?
| | Safety | 1 | 2004 | 357 | 0.010 |
Why?
| | Renal Insufficiency | 1 | 2004 | 171 | 0.010 |
Why?
| | Medical Errors | 1 | 2003 | 123 | 0.010 |
Why?
| | Mice, Inbred C3H | 1 | 2002 | 257 | 0.010 |
Why?
| | Receptors, Tumor Necrosis Factor, Type II | 1 | 2001 | 42 | 0.010 |
Why?
| | Probability | 1 | 2002 | 308 | 0.010 |
Why?
| | Biopsy, Needle | 1 | 2002 | 190 | 0.010 |
Why?
| | Diagnostic Errors | 1 | 2003 | 177 | 0.010 |
Why?
| | Bucladesine | 1 | 2001 | 22 | 0.010 |
Why?
| | Receptors, Tumor Necrosis Factor, Type I | 1 | 2001 | 81 | 0.010 |
Why?
| | Catalase | 2 | 1992 | 134 | 0.010 |
Why?
| | Vinblastine | 2 | 1992 | 72 | 0.010 |
Why?
| | Sialoglycoproteins | 1 | 2002 | 160 | 0.010 |
Why?
| | Spine | 1 | 2003 | 179 | 0.010 |
Why?
| | Toll-Like Receptor 2 | 1 | 2002 | 120 | 0.010 |
Why?
| | Toll-Like Receptors | 1 | 2002 | 188 | 0.010 |
Why?
| | Vagina | 1 | 2003 | 193 | 0.010 |
Why?
| | Nitrites | 1 | 2001 | 88 | 0.010 |
Why?
| | I-kappa B Proteins | 1 | 2001 | 76 | 0.010 |
Why?
| | Interleukin 1 Receptor Antagonist Protein | 1 | 2002 | 255 | 0.010 |
Why?
| | Nitrates | 1 | 2001 | 97 | 0.010 |
Why?
| | omega-N-Methylarginine | 1 | 2000 | 29 | 0.010 |
Why?
| | Guanidines | 1 | 2000 | 42 | 0.010 |
Why?
| | Trachea | 1 | 2002 | 250 | 0.010 |
Why?
| | Arteriosclerosis | 1 | 2000 | 83 | 0.010 |
Why?
| | I-kappa B Kinase | 1 | 2000 | 54 | 0.010 |
Why?
| | Emergency Treatment | 1 | 2001 | 128 | 0.010 |
Why?
| | Renal Dialysis | 1 | 2004 | 460 | 0.010 |
Why?
| | Recurrence | 1 | 2003 | 1114 | 0.010 |
Why?
| | Dogs | 1 | 2001 | 427 | 0.010 |
Why?
| | Toll-Like Receptor 4 | 1 | 2002 | 276 | 0.010 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2002 | 856 | 0.010 |
Why?
| | Nitric Oxide Synthase Type II | 1 | 2000 | 172 | 0.010 |
Why?
| | Interleukin-6 | 1 | 2004 | 781 | 0.010 |
Why?
| | Animals, Newborn | 1 | 2002 | 882 | 0.010 |
Why?
| | Immunoblotting | 1 | 2000 | 313 | 0.010 |
Why?
| | Mice | 3 | 2002 | 18378 | 0.010 |
Why?
| | Tissue Distribution | 1 | 2000 | 330 | 0.010 |
Why?
| | Pulmonary Alveoli | 1 | 2002 | 392 | 0.010 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2002 | 639 | 0.010 |
Why?
| | Fluorescent Antibody Technique | 1 | 2000 | 383 | 0.010 |
Why?
| | Antibodies | 1 | 2001 | 402 | 0.010 |
Why?
| | Niacinamide | 1 | 1999 | 82 | 0.010 |
Why?
| | Histamine Agonists | 1 | 1998 | 1 | 0.010 |
Why?
| | Dimaprit | 1 | 1998 | 3 | 0.010 |
Why?
| | Blood Circulation | 1 | 1998 | 44 | 0.010 |
Why?
| | Vas Deferens | 1 | 1998 | 11 | 0.010 |
Why?
| | Benzamides | 1 | 1999 | 223 | 0.010 |
Why?
| | Prevalence | 1 | 2005 | 2830 | 0.010 |
Why?
| | Recombinant Proteins | 1 | 2002 | 1369 | 0.010 |
Why?
| | Adrenergic beta-Agonists | 1 | 1998 | 97 | 0.010 |
Why?
| | Placebo Effect | 1 | 1997 | 25 | 0.010 |
Why?
| | Escherichia coli | 1 | 2002 | 834 | 0.010 |
Why?
| | Vascular Resistance | 1 | 1998 | 365 | 0.010 |
Why?
| | Muscle Contraction | 1 | 2000 | 430 | 0.010 |
Why?
| | Adenosine Triphosphate | 1 | 1999 | 488 | 0.010 |
Why?
| | Cell Movement | 1 | 2001 | 973 | 0.010 |
Why?
| | Sex Factors | 1 | 2003 | 2092 | 0.010 |
Why?
| | Intraoperative Period | 1 | 1996 | 68 | 0.010 |
Why?
| | Graft Rejection | 1 | 2000 | 551 | 0.010 |
Why?
| | Hospital Costs | 1 | 1997 | 123 | 0.010 |
Why?
| | Energy Metabolism | 2 | 1993 | 939 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2004 | 4182 | 0.010 |
Why?
| | Gene Expression | 1 | 2001 | 1505 | 0.010 |
Why?
| | Iothalamate Meglumine | 1 | 1996 | 2 | 0.010 |
Why?
| | Cholangiography | 1 | 1996 | 9 | 0.010 |
Why?
| | Gallbladder | 1 | 1996 | 14 | 0.010 |
Why?
| | Traction | 1 | 1996 | 19 | 0.010 |
Why?
| | Bile Ducts, Intrahepatic | 1 | 1996 | 61 | 0.010 |
Why?
| | Inflammatory Bowel Diseases | 1 | 2000 | 361 | 0.010 |
Why?
| | Dissection | 1 | 1996 | 55 | 0.010 |
Why?
| | Clinical Trials as Topic | 1 | 2000 | 1043 | 0.010 |
Why?
| | Single-Blind Method | 1 | 1996 | 294 | 0.010 |
Why?
| | DNA | 1 | 2001 | 1457 | 0.010 |
Why?
| | Phenethylamines | 1 | 1993 | 19 | 0.010 |
Why?
| | Mice, Knockout | 1 | 2000 | 3109 | 0.010 |
Why?
| | Adenosine | 1 | 1994 | 251 | 0.010 |
Why?
| | Norepinephrine | 1 | 1993 | 192 | 0.010 |
Why?
| | Ibuprofen | 1 | 1992 | 82 | 0.010 |
Why?
| | Nitroblue Tetrazolium | 1 | 1991 | 12 | 0.010 |
Why?
| | Ventricular Function | 1 | 1991 | 57 | 0.010 |
Why?
| | Tungsten | 1 | 1991 | 30 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 2002 | 4522 | 0.010 |
Why?
| | Chemotaxis, Leukocyte | 1 | 1991 | 115 | 0.010 |
Why?
| | Arrhythmias, Cardiac | 1 | 1993 | 348 | 0.010 |
Why?
| | Azepines | 1 | 1991 | 100 | 0.010 |
Why?
| | Staining and Labeling | 1 | 1991 | 153 | 0.010 |
Why?
| | N-Formylmethionine Leucyl-Phenylalanine | 1 | 1990 | 39 | 0.010 |
Why?
| | Amino Acid Chloromethyl Ketones | 1 | 1990 | 24 | 0.010 |
Why?
| | Permeability | 1 | 1991 | 169 | 0.010 |
Why?
| | Endothelium | 1 | 1991 | 119 | 0.010 |
Why?
| | Triazoles | 1 | 1991 | 168 | 0.000 |
Why?
| | Cell Adhesion | 1 | 1991 | 456 | 0.000 |
Why?
| | Liver Transplantation | 1 | 1996 | 814 | 0.000 |
Why?
| | Kinetics | 1 | 1992 | 1628 | 0.000 |
Why?
| | Biomechanical Phenomena | 1 | 1990 | 867 | 0.000 |
Why?
| | Proteins | 1 | 1991 | 1022 | 0.000 |
Why?
| | Diet | 1 | 1991 | 1290 | 0.000 |
Why?
|
|
Bensard's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|